fbpx
loading

In Singapore, tumours must be on the Ministry of Health’s indication list in order to be treated and insurance-claimable. This regulation takes into account cost-effectiveness, patient’s prognosis, tumour type and location etc. Please refer to MOH website for further information.

Other than conditions listed in the table, tumours like adult low grade glioma, mediastinal thymoma, left breast cancer etc are not specifically listed. However, on a case by case basis, exceptions can be made as stated in the clause.

Treatment should be given with a curative intent.

Patients of all agesNotesNumber of fractions
Musculoskeletal system
– ChordomaUp to 35
– Chondrosarcoma Up to 37
– Spinal and para-spinal bone and soft tissue sarcomasUp to 37
– Retroperitoneal sarcomasUp to 35
– Sarcomas requiring concurrent chemotherapyUp to 37
Central and peripheral nervous system
– EpendymomaUp to 33
– Pituitary adenomaUp to 30
– Base of skull meningiomaUp to 30
– Acoustic neuroma5 or 30# is dependent on size5 or 30
– GliomaUp to 30
Head and neck
– Unresectable head and neck cancersUp to 35
– Cancers of the paranasal sinuses and other accessory sinusesUp to 35
– Oropharyngeal cancerUp to 35
– Nasopharyngeal carcinomaUp to 33
– Mucosal melanomaUp to 35
– Post-operative with chemotherapyUp to 33
Gastro-intestinal
– EsophagealUp to 30
– Unresectable liver cancerUp to 20
– Unresectable pancreatic cancerwith chemotherapyUp to 30#
– Rectal cancerwith chemotherapy, for dose escalation, or for locally recurrenceUp to 30#
Urological
– ProstateUp to 20#
– Bladderwith chemotherapyUp to 33#
Thorax
– Lungwith chemotherapyUp to 33#
– Thymic carcinomawith chemotherapyUp to 30#
Patients younger than 25 years old
Central and peripheral nervous system
– Chordoma/ chondrosarcoma base of skull or spineUp to 40#
– EpendymomaUp to 39#
– CraniopharyngiomaUp to 30#
– Primitive neuroectodermal tumoursUp to 33#
– GliomaUp to 30#
– NeuroblastomaUp to 20#
– MedulloblastomaUp to 33#
Musculoskeletal
– Ewing, rhabdomyosaromaUp to 30#
– OsteosarcomaUp to 35#
– Paraspinal bone and soft tissue sarcomaUp to 35#